{"id":"W2135996840","doi":"10.1016/s1665-2681(19)31482-6","title":"Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patients( )","year":2012,"lang":"en","type":"article","venue":"Annals of Hepatology","topic":"Hepatitis C virus research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"National Center for Research Resources; National Cancer Institute; National Institutes of Health; University of Florida","keywords":"Medicine; Ribavirin; Internal medicine; Adverse effect; Gastroenterology; Peginterferon alfa-2a; Regimen; Neutropenia; Randomized controlled trial; Sofosbuvir; Hepatitis C virus; Immunology; Virus; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002825079,0.001751101,0.002610252,0.0003928203,0.000464138,0.001306472,0.0008401466,0.001726508,0.006468158],"category_scores_gemma":[0.002066724,0.0008858627,0.001757576,0.0003347729,0.001026427,0.001154003,0.0004883087,0.003205918,0.0009077892],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006060443,"about_ca_system_score_gemma":0.001140776,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005938788,"about_ca_topic_score_gemma":0.001165968,"domain_scores_codex":[0.9989219,0.0006899689,0.00005999303,0.0001565036,0.00004604802,0.0001255585],"domain_scores_gemma":[0.9988103,0.000354973,0.0003023648,0.00009546959,0.00007092019,0.000366023],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9881976,0.004208297,0.0002413977,0.0002330156,0.000330182,0.00002209311,0.00003267231,0.0001222889,0.001046488,0.00004696864,0.0002552653,0.005263749],"study_design_scores_gemma":[0.958626,0.03991769,0.0006201509,0.00001702429,0.0002093781,0.00001461272,0.00001119821,0.0001662565,0.0001485564,0.00006610069,0.0001963537,0.000006714979],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9897439,0.002997438,0.0003530408,0.00069781,0.0006252796,0.003324703,0.0005203294,0.00009446957,0.001642926],"genre_scores_gemma":[0.9866534,0.002177457,0.001392726,0.001276526,0.0006074957,0.004901043,0.0006827752,0.0000205849,0.002287995],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006468158,"threshold_uncertainty_score":0.0216381,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07966483117321732,"score_gpt":0.3849926111109822,"score_spread":0.3053277799377649,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}